Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 50.76m | - |
| Gross profit | 18.39m | - |
| Net profit | -1.52m | - |
| EBITDA | 8.98m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €82.12m |
Number of shares | 319.77m |
52-week high/low | €0.38 - €0.25 |
Dividends TTM | €0.00141 |
Beta | 0.34 |
P/E ratio | 292.86 |
PEG ratio | -3.03 |
P/B ratio | 0.59 |
P/S ratio | 0.83 |
Company profile
EuroEyes International Eye Clinic Limited provides vision correction services in Germany, Denmark, and the People's Republic of China. The company offers refractive laser surgery, which include ReLEx SMILE and FemtoLASIK; phakic lens (ICL) surgery; lens exchange surgery comprising the monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. Its correction services are used for the treatment of myopia, high myopia, presbyopia, and cataract. The company serves mid-to-high income level customers, who primarily seek surgery to treat their myopia; and above 45 years of age, who primarily seek surgery to treat their presbyopia or cataract. It operates consultation centers and clinics for eye treatment and LASIK centers; and sells pharmaceutical products. The company is also involved in the trading of eye clinic equipment and lenses; and ophthalmic equipment renting and spaces operating activities. EuroEyes International Eye Clinic Limited was founded in 1993 and is headquartered in Hamburg, Germany.
| Name | EuroEyes International Eye Clinic |
| CEO | Jørn Slot Jørgensen |
| Headquarters | Hamburg,
cq Germany |
| Website | |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| IPO | 15/10/2019 |
| Employees | 409 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Hkse | 1846.HK |